Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Debt / NOTE 1.500% 3/1
-
Market price (% of par)
-
196.32%
-
Total 13F principal
-
$523,444,220
-
Principal change
-
+$13,408,298
-
Total reported market value
-
$1,028,074,923
-
Number of holders
-
60
-
Value change
-
+$29,356,171
-
Number of buys
-
22
-
Number of sells
-
24
Institutional Holders of SALIX PHARMACEUTICALS INC - NOTE 1.500% 3/1 as of Q2 2014
As of 30 Jun 2014,
SALIX PHARMACEUTICALS INC - NOTE 1.500% 3/1 was held by
60 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$523,444,220
in principal (par value) of the bond.
The largest 10 bondholders included
Citadel Advisors LLC, Calamos Advisors LLC, Invesco Ltd., MACKAY SHIELDS LLC, BANK OF AMERICA CORP /DE/, SYMPHONY ASSET MANAGEMENT LLC, SILVERBACK ASSET MANAGEMENT LLC, BAKER BROS. ADVISORS LP, CAMDEN ASSET MANAGEMENT L P /CA, and LORD, ABBETT & CO. LLC.
This page lists
60
institutional bondholders reporting positions
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.